CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 674893-675135 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T12910","span":{"begin":0,"end":106},"obj":"Sentence"},{"id":"T7684","span":{"begin":107,"end":123},"obj":"Sentence"},{"id":"T92266","span":{"begin":124,"end":140},"obj":"Sentence"},{"id":"T98271","span":{"begin":141,"end":197},"obj":"Sentence"},{"id":"T20476","span":{"begin":198,"end":213},"obj":"Sentence"},{"id":"T59926","span":{"begin":214,"end":229},"obj":"Sentence"},{"id":"T9569","span":{"begin":230,"end":242},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Interestingly, CX3CR1 (fractalkine receptor) was present on the vast majority of CD4+CD28null T cells (HC: 88.2 ± 3.9%; MS: 82.4 ± 4.7%; RA: 90.4 ± 1.5%) and mostly absent on CD4+CD28+ T cells (HC: 2.6 ± 0.9%; MS: 1.5 ± 0.6%; RA: 2.4 ± 0.5%)."}

{"project":"Epistemic_Statements","denotations":[{"id":"T1469","span":{"begin":0,"end":242},"obj":"Epistemic_statement"}],"text":"Interestingly, CX3CR1 (fractalkine receptor) was present on the vast majority of CD4+CD28null T cells (HC: 88.2 ± 3.9%; MS: 82.4 ± 4.7%; RA: 90.4 ± 1.5%) and mostly absent on CD4+CD28+ T cells (HC: 2.6 ± 0.9%; MS: 1.5 ± 0.6%; RA: 2.4 ± 0.5%)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T222","span":{"begin":0,"end":106},"obj":"Sentence"},{"id":"T223","span":{"begin":107,"end":123},"obj":"Sentence"},{"id":"T224","span":{"begin":124,"end":140},"obj":"Sentence"},{"id":"T225","span":{"begin":141,"end":197},"obj":"Sentence"},{"id":"T226","span":{"begin":198,"end":213},"obj":"Sentence"},{"id":"T227","span":{"begin":214,"end":229},"obj":"Sentence"},{"id":"T228","span":{"begin":230,"end":242},"obj":"Sentence"}],"text":"Interestingly, CX3CR1 (fractalkine receptor) was present on the vast majority of CD4+CD28null T cells (HC: 88.2 ± 3.9%; MS: 82.4 ± 4.7%; RA: 90.4 ± 1.5%) and mostly absent on CD4+CD28+ T cells (HC: 2.6 ± 0.9%; MS: 1.5 ± 0.6%; RA: 2.4 ± 0.5%)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1421","span":{"begin":137,"end":139},"obj":"Phenotype"},{"id":"T1422","span":{"begin":226,"end":228},"obj":"Phenotype"}],"attributes":[{"id":"A1421","pred":"hp_id","subj":"T1421","obj":"http://purl.obolibrary.org/obo/HP_0001370"},{"id":"A1422","pred":"hp_id","subj":"T1422","obj":"http://purl.obolibrary.org/obo/HP_0001370"}],"text":"Interestingly, CX3CR1 (fractalkine receptor) was present on the vast majority of CD4+CD28null T cells (HC: 88.2 ± 3.9%; MS: 82.4 ± 4.7%; RA: 90.4 ± 1.5%) and mostly absent on CD4+CD28+ T cells (HC: 2.6 ± 0.9%; MS: 1.5 ± 0.6%; RA: 2.4 ± 0.5%)."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2794","span":{"begin":120,"end":122},"obj":"Body_part"},{"id":"T2795","span":{"begin":210,"end":212},"obj":"Body_part"}],"attributes":[{"id":"A2794","pred":"uberon_id","subj":"T2794","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"id":"A2795","pred":"uberon_id","subj":"T2795","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"Interestingly, CX3CR1 (fractalkine receptor) was present on the vast majority of CD4+CD28null T cells (HC: 88.2 ± 3.9%; MS: 82.4 ± 4.7%; RA: 90.4 ± 1.5%) and mostly absent on CD4+CD28+ T cells (HC: 2.6 ± 0.9%; MS: 1.5 ± 0.6%; RA: 2.4 ± 0.5%)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4221","span":{"begin":120,"end":122},"obj":"Disease"},{"id":"T4222","span":{"begin":137,"end":139},"obj":"Disease"},{"id":"T4224","span":{"begin":210,"end":212},"obj":"Disease"},{"id":"T4225","span":{"begin":226,"end":228},"obj":"Disease"},{"id":"T76186","span":{"begin":120,"end":122},"obj":"Disease"},{"id":"T18113","span":{"begin":137,"end":139},"obj":"Disease"},{"id":"T66253","span":{"begin":210,"end":212},"obj":"Disease"},{"id":"T99082","span":{"begin":226,"end":228},"obj":"Disease"}],"attributes":[{"id":"A4221","pred":"mondo_id","subj":"T4221","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A4222","pred":"mondo_id","subj":"T4222","obj":"http://purl.obolibrary.org/obo/MONDO_0005272"},{"id":"A4223","pred":"mondo_id","subj":"T4222","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A4224","pred":"mondo_id","subj":"T4224","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A4225","pred":"mondo_id","subj":"T4225","obj":"http://purl.obolibrary.org/obo/MONDO_0005272"},{"id":"A4226","pred":"mondo_id","subj":"T4225","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A95485","pred":"mondo_id","subj":"T76186","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A77283","pred":"mondo_id","subj":"T18113","obj":"http://purl.obolibrary.org/obo/MONDO_0005272"},{"id":"A37506","pred":"mondo_id","subj":"T18113","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"},{"id":"A67740","pred":"mondo_id","subj":"T66253","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A84126","pred":"mondo_id","subj":"T99082","obj":"http://purl.obolibrary.org/obo/MONDO_0005272"},{"id":"A77207","pred":"mondo_id","subj":"T99082","obj":"http://purl.obolibrary.org/obo/MONDO_0008383"}],"text":"Interestingly, CX3CR1 (fractalkine receptor) was present on the vast majority of CD4+CD28null T cells (HC: 88.2 ± 3.9%; MS: 82.4 ± 4.7%; RA: 90.4 ± 1.5%) and mostly absent on CD4+CD28+ T cells (HC: 2.6 ± 0.9%; MS: 1.5 ± 0.6%; RA: 2.4 ± 0.5%)."}